A Better Approach to Remote Care.
Members with chronic conditions need virtual care options that are easy and accessible 24/7, on or offline. You need innovative care strategies that keep members with diabetes, prediabetes, hypertension, and heart failure, healthier.
Commercial Plans
Scale care management and population health initiatives.
Medicare Advantage Plans
Positively impact quality metrics such as STARS, HOS and CAHPS.
Medicaid Plans
Facilitate problem solving on care management calls.
Their Devices. Their Care Team.
Platform insights are informed by the member’s ecosytem. The platform products connect with 300+ consumer wearable devices and 940+ health systems and pharmacies.
Flexible Integration Approach.
Access a flexible, scalable, easy-to-use platform that supports multiple chronic conditions and can integrate with your current systems through technology partnerships.
Close Gaps In Care.
Proactively address gaps in care, care transitions and readmissions, and gain deeper insights into how members are doing.
Better Population Health Insights.
Transform data into knowledge and insights that inform new models of care.
Backed by Significant Clinical Evidence.
50+ peer-reviewed publications, posters and presentations…and counting.
Clinical and Economic Analysis in Type 2 Diabetes.
12-Month Clinical Trial
In a prospective, randomized, controlled study, Quinn et al. (Diabetes Care, 2011) found that individuals with type 2 diabetes whose A1C levels were > 7.5% at the time of enrollment, and who were randomized to use a mobile phone app to help them manage their diabetes in addition to usual care, improved A1C by an average 1.9%. Persons randomized to usual care alone improved A1C by an average of 0.7%. The difference between the intervention group and the control group was 1.2% (P < 0.001) over 12 months.
Methodology- Primary endpoint: change in A1C over one year. Randomization to one of four groups: (1) usual care (n=56), (2) usual care plus patient mobile app/access to web portal for diabetes management (n=23), (3) usual care, mobile app/portal for patient, plus provider access to raw patient data (n=22), and (4) usual care, mobile app/portal for patient, plus patient data tied to decision support for their physician (n=62). 213 patients enrolled; 163 included in the analysis. Limitations- Private insurance only. Study dropout rates required use of mixed-effects statistical modeling to impute missing observations.
The impact of A1C reduction on cost savings.
Study Set Up
Welldoc funded a retrospective analysis with IBM Watson Health to test the relationship between A1C reduction and cost savings.
Data Inputs
IBM Watson Health was provided starting and ending A1C data from 3,000+ BlueStar users with type 2 diabetes.
Study Population
IBM Watson Health ran user data through their MarketScan Database, which captures claims data of more than 200 million individuals in the US.
Medical Expenditures Correlated with A1C Reduction.
Hospitalizations, ER visits, and HCP office visits
Cost of medical devices, supplies, and medications
Cost of comorbid conditions (hypertension, weight, etc.)
Reach At-Risk Populations. At Scale.
Scale up to address the health conditions of the most vulnerable populations while enabling care teams to have direct communication with those most in need of intervention.
Collaborate with Employers and Providers.
Driving down the cost of chronic conditions is going to take all of us. We are extending virtual care and connecting everyone together. From primary care to community care to hospital care and across labs, clinics, health systems and pharmacies, we are closing the gaps.
Drive Engagement and Member Satisfaction.
Maintaining a positive member experience translates into higher satisfaction scores.
